These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 11284711)

  • 1. The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.
    Toyofuku K; Wada I; Spritz RA; Hearing VJ
    Biochem J; 2001 Apr; 355(Pt 2):259-69. PubMed ID: 11284711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble tyrosinase is an endoplasmic reticulum (ER)-associated degradation substrate retained in the ER by calreticulin and BiP/GRP78 and not calnexin.
    Popescu CI; Paduraru C; Dwek RA; Petrescu SM
    J Biol Chem; 2005 Apr; 280(14):13833-40. PubMed ID: 15677452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins.
    Toyofuku K; Wada I; Valencia JC; Kushimoto T; Ferrans VJ; Hearing VJ
    FASEB J; 2001 Oct; 15(12):2149-61. PubMed ID: 11641241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum retention is a common defect associated with tyrosinase-negative albinism.
    Halaban R; Svedine S; Cheng E; Smicun Y; Aron R; Hebert DN
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5889-94. PubMed ID: 10823941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of tyrosinase processing and trafficking by organellar pH and by proteasome activity.
    Watabe H; Valencia JC; Yasumoto K; Kushimoto T; Ando H; Muller J; Vieira WD; Mizoguchi M; Appella E; Hearing VJ
    J Biol Chem; 2004 Feb; 279(9):7971-81. PubMed ID: 14634018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosinase processing and intracellular trafficking is disrupted in mouse primary melanocytes carrying the underwhite (uw) mutation. A model for oculocutaneous albinism (OCA) type 4.
    Costin GE; Valencia JC; Vieira WD; Lamoreux ML; Hearing VJ
    J Cell Sci; 2003 Aug; 116(Pt 15):3203-12. PubMed ID: 12829739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common temperature-sensitive allelic form of human tyrosinase is retained in the endoplasmic reticulum at the nonpermissive temperature.
    Berson JF; Frank DW; Calvo PA; Bieler BM; Marks MS
    J Biol Chem; 2000 Apr; 275(16):12281-9. PubMed ID: 10766867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of wild-type tyrosinase enhances maturation of temperature-sensitive tyrosinase mutants.
    Halaban R; Cheng E; Hebert DN
    J Invest Dermatol; 2002 Aug; 119(2):481-8. PubMed ID: 12190874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional assessment of tyrosinase variants identified in individuals with albinism is essential for unequivocal determination of genotype-to-phenotype correlation.
    Mondal M; Sengupta M; Ray K
    Br J Dermatol; 2016 Dec; 175(6):1232-1242. PubMed ID: 27537549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive tyrosinase associated with peripheral pigmentation in oculocutaneous albinism.
    King RA; Townsend D; Oetting W; Summers CG; Olds DP; White JG; Spritz RA
    J Clin Invest; 1991 Mar; 87(3):1046-53. PubMed ID: 1900307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Molecular Basis of Chemical Chaperone Therapy for Oculocutaneous Albinism Type 1A.
    Teramae A; Kobayashi Y; Kunimoto H; Nakajima K; Suzuki T; Tsuruta D; Fukai K
    J Invest Dermatol; 2019 May; 139(5):1143-1149. PubMed ID: 30447237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Temperature-Dependent Kinetics of Oculocutaneous Albinism-Causing Mutants of Tyrosinase.
    Wachamo SA; Patel MH; Varghese PK; Dolinska MB; Sergeev YV
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculocutaneous albinism type 1: link between mutations, tyrosinase conformational stability, and enzymatic activity.
    Dolinska MB; Kus NJ; Farney SK; Wingfield PT; Brooks BP; Sergeev YV
    Pigment Cell Melanoma Res; 2017 Jan; 30(1):41-52. PubMed ID: 27775880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligosaccharide trimming plays a role in the endoplasmic reticulum-associated degradation of tyrosinase.
    Wang Y; Androlewicz MJ
    Biochem Biophys Res Commun; 2000 Apr; 271(1):22-7. PubMed ID: 10777675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinase gene mutations causing oculocutaneous albinisms.
    Tomita Y
    J Invest Dermatol; 1993 Feb; 100(2 Suppl):186S-190S. PubMed ID: 8433007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
    Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insertion/deletion mutations of type I oculocutaneous albinism in chinese patients from Taiwan.
    Tsai CH; Tsai FJ; Wu JY; Lin SP; Chang JG; Yang CF; Lee CC
    Hum Mutat; 1999 Dec; 14(6):542. PubMed ID: 10571953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.
    King RA; Pietsch J; Fryer JP; Savage S; Brott MJ; Russell-Eggitt I; Summers CG; Oetting WS
    Hum Genet; 2003 Nov; 113(6):502-13. PubMed ID: 13680365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and sequence analysis of the tyrosinase gene from a patient with tyrosinase-positive oculocutaneous albinism.
    Matsunaga J; Takeda A; Tomita Y; Hara M; Shibahara S; Tagami H
    J Dermatol Sci; 1992 May; 3(3):181-5. PubMed ID: 1498098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.